Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MN”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableNot Yet RecruitingNCT07503912
What this trial is testing

Evaluation of the Not A Number Trafficking Prevention Program in Minnesota

Who this might be right for
Commercial Sexual Exploitation
University of New Hampshire 450
Not applicableStudy completedNCT00781703
What this trial is testing

Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN)

Who this might be right for
Major Depression
HealthPartners Institute 2,631
Early research (Phase 1)Study completedNCT00001043
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00000798
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT00011037
What this trial is testing

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 160
Not applicableUnknownNCT06189599
What this trial is testing

Modified antioxIdants Bacteria for Gut Inflammation

Who this might be right for
Chronic Inflammatory Small Bowel Disease
Assistance Publique - Hôpitaux de Paris 500
Early research (Phase 1)Study completedNCT00002428
What this trial is testing

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Early research (Phase 1)Study completedNCT00805753
What this trial is testing

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic 20
Not applicableStudy completedNCT04244773
What this trial is testing

ESTxENDS Trial: MN Substudy - Micronuclei in Buccal Epithelium, a Surrogate Measure of Future Cancer Risk, Induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Who this might be right for
Smoking CessationMicronuclei
University of Bern 1,246
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 200
Not applicableUnknownNCT01152060
What this trial is testing

Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial

Who this might be right for
ProteinuriaHBVe-antigen
Nanchang University 10
Early research (Phase 1)Study completedNCT00000813
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Ended earlyNCT00460460
What this trial is testing

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Who this might be right for
Lymphoma
AstraZeneca 75
Not applicableLooking for participantsNCT06577896
What this trial is testing

The Study to Evaluate the Safety and Efficacy of the Onyx Family

Who this might be right for
Coronary Artery Disease
Pusan National University Yangsan Hospital 500
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd. 84
Early research (Phase 1)Study completedNCT00001096
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00000846
What this trial is testing

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableLooking for participantsNCT07410156
What this trial is testing

Clinical Evaluation of Microneedling Technique With Topical Application of Silymarin on Gingival Hyperpigmentation in Comparison With Diode Laser and Scalpel Methods.

Who this might be right for
Gingival PigmentationGingival Hyperpigmentaion
Fayoum University 30
Testing effectiveness (Phase 2)Study completedNCT01093157
What this trial is testing

A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

Who this might be right for
Glomerulonephritis
University Health Network, Toronto 10
Not applicableLooking for participantsNCT07037927
What this trial is testing

Minnesota RETAIN Phase 3

Who this might be right for
Injuries Related WorkIllness Related WorkDisability
Mayo Clinic 1,000
Load More Results